Cargando…

Efficacy of Plasmapheresis and Immunoglobulin Replacement Therapy (IVIG) on Patients with COVID-19

Since the rapidly evolving outbreak of COVID-19, several empirical therapeutic options have been recommended including the use of antivirals, steroids, and vaccines. According to recent observations about different modalities in treatment of patients infected with COVID-19, plasmapheresis and intrav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pourahmad, Ramtin, Moazzami, Bobak, Rezaei, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392618/ https://www.ncbi.nlm.nih.gov/pubmed/32838178 http://dx.doi.org/10.1007/s42399-020-00438-2

Ejemplares similares

Reassessing IVIg therapy in chronic inflammatory demyelinating polyradiculoneuropathy during COVID-19: a chance to verify the need for chronic maintenance therapy
por: Romozzi, Marina, et al.
Publicado: (2021)

COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment
por: Sadeghmousavi, Shaghayegh, et al.
Publicado: (2020)

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children with COVID-19
por: Sarzaeim, Mojdeh, et al.
Publicado: (2020)

Seizure in patients with COVID-19
por: Emami, Amir, et al.
Publicado: (2020)

Les immunoglobulines anti-COVID en pédiatrie, pour qui, pourquoi, comment ?
por: Mershati, S. El, et al.
Publicado: (2023)

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
por: Papi, Alberto, et al.
Publicado: (2023)

Risk factors for COVID-19 severity and mortality among inpatients in Southern Iran
por: REZAEI, FATEMEH, et al.
Publicado: (2022)

Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis
por: Fatemi, Behzad, et al.
Publicado: (2023)

Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
por: Abolhassani, Hassan, et al.
Publicado: (2022)

Role of Dupilumab in Approved Indications of COVID-19 Patient: an Efficacy-Based Nonsystematic Critical Analysis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2020)

Neurological manifestations of COVID-19 in patients: from path physiology to therapy
por: Merino, J. J., et al.
Publicado: (2021)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
por: Vitiello, Antonio, et al.
Publicado: (2020)

Global sharing of COVID‐19 therapies during a “New Normal”
por: Jecker, Nancy S., et al.
Publicado: (2022)

Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19
por: Zimilover, Adam, et al.
Publicado: (2022)

The arrival of SARS-CoV-2–neutralizing antibodies in a currently available commercial immunoglobulin
por: Miller, Aaron L., et al.
Publicado: (2022)

Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
por: Pontali, Emanuele, et al.
Publicado: (2021)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
por: Ferrara, Francesco, et al.
Publicado: (2020)

Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19
por: Leeson, Cale E., et al.
Publicado: (2020)

Neurological music therapy during the COVID-19 outbreak: updates and future challenges
por: Vinciguerra, Claudia, et al.
Publicado: (2022)

Effects of the COVID-19 pandemic on reperfusion therapy for acute ischemic stroke patients in Huizhou City, China
por: Luo, Weiliang, et al.
Publicado: (2021)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

COVID-19 Recommendations for Patients with Cancer: The post-COVID-19 Era
por: Ismaili, Nabil
Publicado: (2020)

Comparison of Outcomes in Candidemia Between COVID-19 and Non–COVID-19 Patients
por: Beatriz Cruz, Angela, et al.
Publicado: (2021)

The effects of COVID-19 pandemic countermeasures on patients receiving botulinum toxin therapy and on their caregivers: a study from an Italian cohort
por: Tarantino, Domiziano, et al.
Publicado: (2021)

Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study
por: de Watteville, Aude, et al.
Publicado: (2022)

Neuromuscular presentations in patients with COVID-19
por: Paliwal, Vimal Kumar, et al.
Publicado: (2020)

COVID-19 in patients with Down syndrome
por: Emami, Amir, et al.
Publicado: (2021)

Reduction of in-hospital non-COVID-19 pneumonia in stroke patients during the COVID-19 pandemic
por: Ornello, Raffaele, et al.
Publicado: (2023)

Labile PT-INR in a Covid-19 Patient Under Long-term Vitamin K Antagonist Therapy: a Case Report
por: Trevisan, Caterina, et al.
Publicado: (2020)

Psychotherapists’ experiences of telepsychotherapy during the COVID-19 pandemic in Argentina: impact on therapy setting, therapeutic relationship and burden
por: König, Vera Luisa, et al.
Publicado: (2023)

Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis
por: Cau, A., et al.
Publicado: (2021)

Nutrition therapy in the intensive care unit during the COVID-19 pandemic: Findings from the ISIIC point prevalence study
por: Nakamura, Kensuke, et al.
Publicado: (2022)

Selection and Duration of Therapy as a Target for Antimicrobial Stewardship during COVID-19: Levees for a Hundred-Year Flood
por: Mena Lora, Alfredo, et al.
Publicado: (2021)

Lung Ultrasound Findings in Patients with COVID-19
por: Marggrander, Daniel T., et al.
Publicado: (2020)

Comorbidity and its Impact on Patients with COVID-19
por: Sanyaolu, Adekunle, et al.
Publicado: (2020)

Cardiac complications in patients hospitalised with COVID-19
por: Linschoten, Marijke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uvfmgcgvfqsni85pnn3mosif88